No takes yet. Share an insight, caveat, or question.
Preclinical study reveals vaccine protection against SIV is mediated by human host cell antigens in macaques, indicating xenoimmunization drives efficacy.
Cranage et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: